查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198220

視網膜手術器械市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Retinal Surgery Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，視網膜手術設備市場的複合年增長率預計為 7.9%。

COVID-19 對視網膜手術設備市場產生了一些影響，因為視網膜手術通常是需要立即手術的緊急情況。 COVID-19 指南促使世界各地的醫生優先考慮基本程序，包括視網膜手術。 然而，延誤診斷在大流行期間在一定程度上阻礙了患者的健康。 醫生定期進行大流行後手術，大流行後市場將健康增長。

視網膜手術設備通過激光手術、冷凍療法或鞏膜帶扣手術修復撕裂或脫落的視網膜。 視網膜疾病種類繁多，其中許多會引起視覺症狀。 這些疾病會影響視網膜的任何部分，即眼睛內後壁上的薄組織。

根據世界衛生組織 (WHO) 2021 年的數據，據稱到 2050 年，全球 60 歲及以上人口的數量將從 2015 年的 9 億增加到約 20 億。 目前，80歲以上的人口約有1.25億。 老年人群中視網膜疾病、眼睛損傷和糖尿病性視網膜病變患病率的增加是視網膜手術設備市場的主要驅動力。 此外，根據世界衛生組織 2021 年 10 月的一份報告，全球約有 22 億人患有近視或遠視，其中約 10 億人本可以預防。 視力障礙病例的全球負擔很高，表明有治療的潛力。 因此，對眼科藥物的需求非常高，預計這將對本研究預測期內研究的市場增長產生積極影響。

視力喪失專家組 (VEEG) 報告稱，到 2021 年，全球將有 11 億人視力喪失，其中 90% 將生活在中低收入國家 (LMIC)。 此外，根據 2021 年發布的 PubMed 數據，到 2050 年，中東地區的盲人人數將從目前的 4300 萬增加到 6100 萬（增長 42%）。 同樣，中度至重度失明的人數將從目前的 2.95 億增加到 4.74 億（增加 61%）。 到2050年，輕度視力障礙人數將從2.58億增加到3.6億，近視力障礙人數將從目前的5.1億增加到8.66億（增長70%）。。 該數據表明，眼科疾病呈上升趨勢，推動了預測期內的市場增長。

然而，與視網膜手術相關的並發症和高昂費用是阻礙市場增長的因素之一。

視網膜手術設備市場趨勢

糖尿病視網膜病變領域有望在未來幾年實現健康增長

糖尿病性視網膜病變是糖尿病患者視網膜血管受損引起的一種疾病。 糖尿病視網膜病變可能發生在 1 型或 2 型糖尿病患者以及有不受控制的高血糖病史的患者身上。 有兩種類型的糖尿病性視網膜病變。 糖尿病視網膜病變有兩種類型：非增殖性糖尿病視網膜病變（NPDR），其中眼睛在糖尿病視網膜病變的早期不能形成新血管，以及增殖性糖尿病視網膜病變（PDR），其中新血管開始生長在視網膜中。並且 PDR 在視網膜中形成新血管之前發展。

根據國際糖尿病聯合會 (IDF) 的數據，大約 4.63 億 20-79 歲的成年人患有糖尿病。 到 2045 年，預計將增加到 7 億人，79% 的糖尿病成年人將生活在低收入和中等收入國家。 隨著全球糖尿病負擔的增加，糖尿病視網膜病變手術的需求預計將增加，預計將在預測期內推動市場增長。

此外，根據《印度眼科雜誌》2021 年的數據，2021 年糖尿病視網膜病變的患病率男性約為 17%，女性約為 11.8%。 此外，2021 年 11 月發布的 PubMed 數據表明，2021 年糖尿病視網膜病變的全球患病率約為 22.27%，到 2045 年將增加。 因此，隨著全球糖尿病視網膜病變患病率的上升，預計該細分市場在預測期內將出現顯著增長。

北美將佔據很大的市場份額，預計在預測期內也會如此

北美預計將在全球視網膜手術設備市場佔據重要市場份額，因為該地區老年人口視網膜疾病患病率上升，糖尿病性視網膜病變患病率高。.

例如，根據疾病預防控制中心的數據，到 2021 年，美國約有 1200 萬 40 歲以上的人會出現視力障礙。 細分為 100 萬失明者、300 萬矯正後視力受損者和 800 萬未矯正屈光不正視力受損者。 此外，在美國，大約 6.8% 的 18 歲以下兒童被診斷出患有眼睛或視力障礙。 此外，將近 3% 的 18 歲以下兒童被定義為“盲人”或“視力受損”，這使得即使戴著眼鏡或隱形眼鏡也難以看清東西。 因此，全美國日益增加的視力障礙負擔正在推動對視網膜手術的需求。

此外，《美國醫學會雜誌》的數據表明，整個北美地區的糖尿病患病率逐年上升。 它還導致糖尿病視網膜病變增加，佔大多數。 例如，國際糖尿病聯合會表示，到 2021 年，大約 10.5% 的美國人口將患有糖尿病，並且這一數字將在未來幾年呈指數增長。 因此，糖尿病的負擔在全國范圍內不斷增加，所研究的市場預計在預測期內將出現顯著增長。

此外，加拿大正在轉向新的眼科手術醫院，以滿足日益增長的眼科手術需求。 例如，2022 年 10 月，位於加拿大溫莎的溫莎外科中心開設了一個佔地 12,000 平方英尺的新設施，為每年需要進行眼科手術的數千人提供服務。 因此，隨著眼科中心數量的增加，預計未來幾年加拿大的市場將出現強勁增長。

視網膜手術器械市場競爭對手分析

視網膜手術市場是一個競爭激烈的市場，由幾家主要參與者組成。 就市場份額而言，它目前由幾家主要參與者主導。 一些大公司正在積極收購其他公司以鞏固其在全球市場的地位。 一些市場參與者包括 Alcon Inc、IRIDEX Corporation、Bausch & Lomb Incorporated、Carl Zeiss Meditec AG、Topcon Corporation、NIDEK、Ellex Medical Lasers、Lumenis、Leica Microsystems GMBH。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 老年人口不斷增加，眼病患病率不斷上升
    • 對微創手術的需求不斷增加
  • 市場製約因素
    • 視網膜手術設備成本高
    • 與視網膜手術相關的並發症
  • 波特的五力分析
    • 供應商的議價能力
    • 買方/消費者議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（市場規模：百萬美元）

  • 按產品類型
    • 玻璃體手術設備和包
    • 視網膜激光設備
    • 手術器械
    • 其他產品
  • 通過申請
    • 糖尿病視網膜病變
    • 視網膜脫離
    • 其他用途
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Alcon, Inc
    • IRIDEX Corporation
    • Bausch & Lomb Incorporated
    • Carl Zeiss Meditec AG
    • Topcon Corporation
    • NIDEK CO., LTD
    • Ellex Medical Lasers
    • Lumenis
    • Leica Microsystems GmbH

第7章 市場機會今後動向

簡介目錄
Product Code: 67635

The retinal surgery devices Market is expected to register a CAGR of 7.9% during the forecast period.

COVID-19 had a slight impact on the retinal surgery devices market as retinal surgery is usually an emergency where an instant operation is needed. With the COVID-19 guidelines, doctors have taken essential procedures on priority across the globe, which also included retinal surgeries. However, a delay in diagnosing the disease has hampered the patient's well-being to some extent during the pandemic. Doctors are performing post-pandemic surgeries regularly, and the market will witness healthy growth over the post-pandemic era.

Retinal surgical devices repair torn or detached retinas through laser surgery, cryotherapy, scleral buckle surgery, etc. Retinal diseases vary widely, but most of them cause visual symptoms. They can affect any part of the retina, a thin layer of tissue on the inside back wall of your eye.

According to the World Health Organization (WHO) 2021 data, by the year 2050, the world's population aged 60 years and older will reach approximately 2 billion, up from 900 million in 2015. Currently, about 125 million people are aged 80 years or older. Growing retinal disorders in the geriatric population, eye injuries, and the rising prevalence of diabetic retinopathy are the key driving factors in the retinal surgery devices market. Further, according to the October 2021 WHO report, about 2.2 billion people worldwide have near or distant vision impairment, of which approximately 1 billion cases could have been prevented. It shows the high burden of cases of vision impairment worldwide and the possibility of treatment. That is why there is a very high demand for ophthalmic drugs, which will positively impact the growth of the market studied during the forecast period of the study.

The Vision Loss Expert Group (VEEG), in 2021, reported that globally 1.1 billion people live with vision loss and 90% of such people live in low and middle-income countries (LMICs). Additionally, PubMed data published in 2021 indicates that the number of blind people will increase from the current 43 million to 61 million (42% increase) by the year 2050 in the Middle East region. Similarly, those with moderate to severe visual impairment will increase from the current 295 million to 474 million (61% increase). People with mild visual impairment will rise from 258 million to 360 million, and those with near vision difficulties will increase from the recent 510 million to 866 million (70% increase) by 2050. The data shows that ophthalmic diseases are rising, propelling the market's growth over the forecasted period.

However, complications associated with retinal surgery and the high cost are some of the factors that can hinder market growth.

Retinal Surgery Devices Market Trends

Diabetic Retinopathy Segment is Expected to Witness Healthy Growth in the Coming Years

Diabetic retinopathy is a condition resulting from damage to the retinal blood vessels in people with diabetes. Diabetic retinopathy can develop in people with type 1 or type 2 diabetes and with a history of uncontrolled high blood sugar levels. Diabetic retinopathy is of two kinds: Nonproliferative diabetic retinopathy (NPDR), in which the eye cannot make new blood vessels during early diabetic retinopathy, and proliferative diabetic retinopathy (PDR), in which new blood vessels begin to grow within the retina.

As per International Diabetes Federation (IDF), approximately 463 million adults aged 20-79 will be living with diabetes. By 2045, it is expected to rise to 700 million adults with diabetes, and 79% of adults who have diabetes will be from low- and middle-income countries. With the increasing burden of diabetes globally, there will be a growing demand for diabetic retinopathy surgeries, which will boost the market growth in the forecast period.

Additionally, according to the Indian Journal of Ophthalmology data in 2021, the diabetic retinopathy prevalence in 2021 was around 17% in males and 11.8% in females. Furthermore, the PubMed data published in November 2021 suggests that the global prevalence of diabetic retinopathy was nearly 22.27% as of 2021, which will increase by 2045. Hence, with the rising worldwide prevalence of diabetic retinopathy, the segment is expected to witness substantial growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global retinal surgery devices market due to the rising prevalence of retinal disorders in the geriatric population and the high prevalence of diabetic retinopathy in this region.

For instance, in 2021, according to the CDC, approximately 12 million people 40 years and over in the US had vision impairment. The number includes 1 million who were blind, 3 million who had vision impairment after correction, and 8 million who had vision impairment due to uncorrected refractive error. Additionally, approximately 6.8% of children younger than 18 years in the US had a diagnosed eye and vision condition. Nearly 3% of children younger than 18 years were blind or visually impaired, defined as having trouble seeing even when wearing glasses or contact lenses. Hence, with the rising burden of vision problems across the country, there is a growing demand for retinal surgeries.

Furthermore, data from the Journal of the American Medical Association suggests that the prevalence of diabetes across the North American region is increasing annually. It is also causing an increase in the majority of diabetic retinopathy. For instance, the International Diabetes Federation has stated around 10.5% of the US population was suffering from diabetes during 2021, and this will grow exponentially in the coming years. Hence, with an increasing burden of diabetes across the country, the market studied is expected to witness substantial growth over the forecasted period.

Additionally, in Canada, there has been an increasing focus on new eye surgery hospitals to fulfill the rising demand for ophthalmic surgeries. For instance, in October 2022, Windsor Surgical Centre, located in Windsor, Canada, opened a new 12,000 Sq.ft facility to serve thousands of people requiring eye surgery annually. Hence, with the rising number of ophthalmic centers, the market studied is expected to witness strong growth in Canada during the coming years.

Retinal Surgery Devices Market Competitor Analysis

The retinal surgery devices Market is consolidated and competitive and consists of several major players. In terms of market share, a few major players are currently dominating it. Some prominent players are vigorously making acquisitions with other companies to consolidate their global market positions. Some market players are Alcon Inc, IRIDEX Corporation, Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Topcon Corporation, NIDEK CO., LTD, Ellex Medical Lasers, Lumenis, Leica Microsystems GMBH.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population and Increasing Prevalence of Eye Diseases
    • 4.2.2 Increasing Demand for Minimally Invasive Surgeries
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Retinal Surgery Devices
    • 4.3.2 Complications Associated with the Retinal Surgeries
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size - Value in USD million)

  • 5.1 By Product Type
    • 5.1.1 Vitrectomy Machines and Packs
    • 5.1.2 Retinal Laser Equipment
    • 5.1.3 Surgical Instruments
    • 5.1.4 Other Products
  • 5.2 By Application
    • 5.2.1 Diabetic Retinopathy
    • 5.2.2 Retinal Detachment
    • 5.2.3 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alcon, Inc
    • 6.1.2 IRIDEX Corporation
    • 6.1.3 Bausch & Lomb Incorporated
    • 6.1.4 Carl Zeiss Meditec AG
    • 6.1.5 Topcon Corporation
    • 6.1.6 NIDEK CO., LTD
    • 6.1.7 Ellex Medical Lasers
    • 6.1.8 Lumenis
    • 6.1.9 Leica Microsystems GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS